Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Silver

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Molecular Cancer Therapeutics|December 11, 2025
MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer TherapyManish Neupane, Mukesh Kumar, Malela A Mwamufiya, et al.
Breast Cancer Research : BCR|March 8, 2017
Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cellsJessalyn M Ubellacker, Marie-Therese Haider, Molly J DeCristo, et al.
Cell|July 14, 2009
Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cellsIlona Kalaszczynska, Yan Geng, Tadafumi Iino, et al.
Biomarker Research|May 28, 2015
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugsAndrea M Marquard, Aron C Eklund, Tejal Joshi, et al.
NPJ Breast Cancer|June 2, 2021
Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancerRui Luo, Weelic Chong, Qiang Wei, et al.
Cancers|June 24, 2022
Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance MechanismMaysa Abu-Khalaf, Chun Wang, Zhenchao Zhang, et al.
Cancer Discovery|November 8, 2015
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in MalignancyManish Neupane, Allison P Clark, Serena Landini, et al.
Cell|March 14, 2007
Further evidence for BRCA1 communication with the inactive X chromosomeDaniel P Silver, Stoil D Dimitrov, Jean Feunteun, et al.
Cell|November 7, 2002
BRCA1 supports XIST RNA concentration on the inactive X chromosomeShridar Ganesan, Daniel P Silver, Roger A Greenberg, et al.
Cancer Discovery|May 12, 2012
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agentsNicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Molecular Cancer Therapeutics|December 11, 2025
MECP2-Dependent Cancers Can Be Targeted by Epigenetic Drugs: A New Role for Epigenetic Cancer TherapyManish Neupane, Mukesh Kumar, Malela A Mwamufiya, et al.
Breast Cancer Research : BCR|March 8, 2017
Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cellsJessalyn M Ubellacker, Marie-Therese Haider, Molly J DeCristo, et al.
Cell|July 14, 2009
Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cellsIlona Kalaszczynska, Yan Geng, Tadafumi Iino, et al.
Biomarker Research|May 28, 2015
Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugsAndrea M Marquard, Aron C Eklund, Tejal Joshi, et al.
NPJ Breast Cancer|June 2, 2021
Whole-exome sequencing identifies somatic mutations and intratumor heterogeneity in inflammatory breast cancerRui Luo, Weelic Chong, Qiang Wei, et al.
Cancers|June 24, 2022
Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance MechanismMaysa Abu-Khalaf, Chun Wang, Zhenchao Zhang, et al.
Cancer Discovery|November 8, 2015
MECP2 Is a Frequently Amplified Oncogene with a Novel Epigenetic Mechanism That Mimics the Role of Activated RAS in MalignancyManish Neupane, Allison P Clark, Serena Landini, et al.
Cell|March 14, 2007
Further evidence for BRCA1 communication with the inactive X chromosomeDaniel P Silver, Stoil D Dimitrov, Jean Feunteun, et al.
Cell|November 7, 2002
BRCA1 supports XIST RNA concentration on the inactive X chromosomeShridar Ganesan, Daniel P Silver, Roger A Greenberg, et al.
Cancer Discovery|May 12, 2012
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agentsNicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, et al.
Pageof 3